The Kidney Cancer Association (KCA) is proud to present IKCS 2020, the 19th annual meeting of the International Kidney Cancer Symposium taking place November 6th and 7th virtually. This annual event, along with the KCA’s European International Kidney Cancer Symposium (EIKCS) held each spring, is an opportunity for physicians, researchers, academics, and industry professionals from across the globe to join together and exchange ideas which will direct the future of kidney cancer research and treatment in the ultimate pursuit of a cure.

IKCS 2019 was the highest-attended symposium to date with more than 450 registered attendees – increasing attendance nearly 34% from the year prior. IKCS presenters and attendees travel from Europe, Asia, South America, and dozens of cities across the United States to participate in the symposium. Event highlights include the presentation of the organization’s Eugene P. Schonfeld Award. Named in honor of the founder, the award recognizes a health care professional who has made significant contributions in the treatment of renal cell carcinoma.

IKCS strives to offer a balanced agenda with meaningful content on topics such as emerging research, noteworthy breakthroughs, current challenges, promising treatments, and patient-focused issues. The symposium also serves as an introduction to the organization’s newest class of Advanced Discovery Award and Young Investigator Award recipients, who are frequent presenters or moderators throughout the course of the symposium schedule.

Each year’s symposium is crafted to optimize a collective opportunity for learning, discussion, mentorship, camaraderie and collaboration not only on how best to care for our patients but to ultimately move the needle toward the next discovery.

As a keystone event for the KCA, IKCS aligns key aspects of the organization’s mission – to be a global community and leading change through advocacy, research, and education – all in the name of serving and empowering kidney cancer patients and their caregivers.

The Kidney Cancer Association was founded in 1990 by Eugene P. Schonfeld and a small group of patients and doctors in Chicago, Illinois and has grown into an international non-profit organization. The KCA promotes scientific advances through two annual research symposia and a robust grant program, participates in legislative advocacy, and seeks to be a source of education and resources for patients, caregivers, and anyone impacted by kidney cancer.

Our vision is to be the universal leader in finding the cure for kidney cancer.

Our mission is to be a global community dedicated to serving and empowering patients and caregivers, and leading change through advocacy, research, and education.